Broad cost-cutting initiatives continue at Pfizer, following their 2023 acquisition of Seattle's first biotech company, Seagen.

Now, 100 more workers to be let go

A WARN Alert from the WA State Employment Security Office indicates as of this week, 100 workers will be let go.

Pfizer purchased SeaGen for $43 billion in 2023. The acquisition included a major manufacturing project in Everett, but Pfizer halted that production, cutting 119 jobs.

Now, following their vacating the 61,000-square-foot former SeaGen headquarters, they're letting go another1 100 workers.

Several sources indicate these are part of cost-cutting measures at the company designed to reduce expenses and other financial challenges. The sources say Pfizer has been plagued by declining COVID-19 product sales as wel

See Full Page